16.3 C
Innichen
June 28, 2022
Science and Medical

ADA: Lilly’s Trulicity cuts heart risks by 12%. Is it enough to fend off Novo’s semaglutide? – FiercePharma

ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off Novo's semaglutide? - FiercePharma thumbnail

SAN FRANCISCOBack in November, news of a cardiovascular outcomes win for Trulicity pleased Eli Lilly investors whom analysts called skeptical. Now, those same skeptics may wonder just how well Trulicitys performance can help it fend off new competition from N…
Read More

Related posts

Frequent urination at night is more common as we age – The Washington Post

Administrator

I ate nothing but melon for five days straight, and here’s what I learned – WJLA

Administrator

6 Foods to Eat for Healthier Eyes and Better Vision – Real Simple

Administrator

Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Policy